However, the expression of uPAR is dramatically upregulated after CRT 157, and recent results suggest that PAI-1 but not uPA and uPAR might have prognostic value for patients with advanced non-small-cell lung cancer (NSCLC) undergoing radiotherapy 158. This evidence concerns the gene PLAU and non-small cell lung carcinoma.